Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001317757-10-000022)

Filing Details

Accession Number:: 0001317757-10-000022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-09 13:00:00
Reporting Period:: 2010-08-06

Filing Date:: 2010-08-09
Accepted Time:: 2010-08-09 16:23:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	In Vitro & In Vivo Diagnostic Substances (2835)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1465314	Ricardo Zayas	100 Hayden Avenue Lexington MA 02421	Svp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-08-06	5,790	$0.00	5,102	No	4	S	Direct
Common Stock	Disposition	2010-08-09	10	$30.65	5,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold on this day. The actual sales prices range from $31.091-$31.19. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.